Vitamin K deficiency bleeding
Also known as: hemorrhagic disease of the newborn, VKDB
What is hemorrhagic disease of the newborn?
Vitamin k plays an important role in blood clotting (coagulation); particularly being associated with coagulation factors V11, 1X, and X. When there is a lack of Vit k blood doesn't clot and bleeding results. In the newborn baby depending on the cause of the vitamin deficiency, bleeding time after birth can vary quite widely (mostly however between the ages of 1-5 days). Bleeding after birth is usually classified into 3 distinct time periods ("Early-onset" deficiency bleeding occurring during the first 24 hours; "Classical" vit k deficiency with bleeding 24 hours, to up to 1 week after birth; and "Late-onset" Vit k deficiency bleeding usually occurring between 2 - 12 weeks after birth.
What causes hemorrhagic disease of the newborn?
Depending on when bleeding after birth occurs, so causes will differ. "Classical" vit k deficiency results from poor transfer of vit k from mother to baby during pregnancy and before the baby is capable of making his/ her own vit k.
What are the signs/symptoms of hemorrhagic disease of the newborn?
Bleeding can be seen in the skin/mucus membranes (bruises), from the penis (bloody urine), belly button, gastrointestinal tract (bloody vomit or stool), and into the brain which can result in seizures. Bleeding into internal organs may occur and may be difficult to detect.
What are hemorrhagic disease of the newborn care options?
An intramuscular injection of vitamin K after birth for "Classical" vit k deficiency bleeding is usually sufficient to stop the bleeding. Other blood factors and /or treatments may be needed for the other causes of bleeding after birth.
Reviewed by: Jack Wolfsdorf, MD, FAAP
This page was last updated on: 5/24/2018 11:04:42 AM
From the Newsdesk
We are pleased to announce the Fetal Care Center’s special delivery unit is expected to open in the summer of 2019. This special delivery unit will offer a smooth transfer of care and access to our network of pediatric subspecialists and our three pediatric intensive care units.
Dr. Ossama Maher is the Associate Director of the Pediatric Neuro-Oncology Program at Nicklaus Children's Hospital. For more information, please visit nicklauschildrens.org/Cancer